Table 2 Linear regression analysis of CHHF with adipokine levels
Model 1 | Model 2 | Model 3 | ||||
|---|---|---|---|---|---|---|
Traitsa | Beta (95% CI) | P value | Beta (95% CI) | P value | Beta (95% CI) | P value |
All | ||||||
Adiponectin (μg/mL) | 1.33 (1.16, 1.53) | 4.44 × 10-5 | 1.23 (1.07, 1.40) | 3.28 × 10-3 | 1.18 (1.02, 1.35) | 2.32 × 10-2 |
Leptin (ng/mL) | −2.32 (−7.67, 1.42) | 0.168 | −1.49 (−5.06, 2.27) | 0.521 | 1.10 (−3.19, 3.84) | 0.59 |
LAR | −1.38 (−1.68, −1.14) | 1.28 × 10-3 | −1.22 (−1.48, 1.00) | 4.62 × 10-2 | −1.12 (−1.37, 1.09) | 0.262 |
Men | ||||||
Adiponectin (μg/mL) | 1.26 (−1.02, 1.60) | 0.0686 | 1.21 (−1.04, 1.52) | 0.113 | 1.13 (−1.13, 1.43) | 0.332 |
Leptin (ng/mL) | 1.50 (−3.45, 7.80) | 0.628 | 1.64 (−3.23, 8.66) | 0.562 | 1.85 (−3.09, 10.5) | 0.163 |
LAR | −1.27 (−1.77, 1.10) | 0.164 | −1.21 (−1.67, 1.15) | 0.268 | −1.09 (−1.53, 1.29) | 0.636 |
Women | ||||||
Adiponectin (μg/mL) | 1.40 (1.19, 1.66) | 7.87 × 10-5 | 1.27 (1.08, 1.50) | 3.17 × 10-3 | 1.23 (1.04, 1.45) | 1.80 × 10-2 |
Leptin (ng/mL) | −4.38 (−22.2, 1.16) | 0.0752 | −2.35 (−2.51, 2.22) | 0.311 | −1.22 (−6.49, 4.39) | 0.334 |
LAR | −1.48 (−1.89, −1.15) | 2.03 × 10-3 | −1.26 (−1.61, 1.01) | 0.0611 | −1.16 (−1.49, 1.10) | 0.233 |